Raynaud's phenomenon, first described by Maurice Raynaud in 1888,' is characterised by attacks of digital pallor due to constriction of small arteries or arterioles on exposition to cold or, less commonly, emotional stimuli. The white discoloration is followed by a cyanotic phase, resulting from stagnated blood flow in dilated capillaries and venules. Reactive hyperaemia, probably produced by local accumulation of vasodilating agents in ischaemic tissue, causes rubor on warming up. The cause of Raynaud's phenomenon is largely unknown. It has been reported to occur in some 10% of the population, especially in young women, and clusters in certain families. anticentromere, directed against the CENP-B antigen, for limited cutaneous scleroderma including CREST (calcinosis, Raynaud's phenomenon, oesophageal dysmotility, sclerodactyly, telangiectasia), and anti-topoisomerase 1, also known as anti-Scl-70 or anti-Scl-86, for (diffuse) scleroderma,4 12 13 Finally, nailfold capillary microscopy might be a tool for the early detection of connective tissue disease in patients with Raynaud's phenomenon. It discloses loss of capillaries and dilated and deformed capillaries in patients with Raynaud's phenomenon and (symptoms of) connective tissue disease, whereas capillary patterns are normal in patients with primary Raynaud's phenomenon.1446 Loss of nailfold capillaries may be considered as a local manifestation of a more generalised vasculopathy as suggested by the correlation between the reduction in the number of capillaries in the nail fold and the decrease of the pulmonary diffusing capacity in patients with Raynaud's phenomenon with and without an underlying connective tissue disease.'7 18 The predictive value of nailfold capillary microscopy for the development of connective tissue disease has been suggested, '9 20 
